ICU Medical Future Growth

Future criteria checks 3/6

ICU Medical is forecast to grow earnings and revenue by 54% and 2.4% per annum respectively. EPS is expected to grow by 54.1% per annum. Return on equity is forecast to be 4.2% in 3 years.

Key information

54.0%

Earnings growth rate

54.1%

EPS growth rate

Medical Equipment earnings growth16.1%
Revenue growth rate2.4%
Future return on equity4.2%
Analyst coverage

Low

Last updated29 Feb 2024

Recent future growth updates

Recent updates

Is ICU Medical, Inc. (NASDAQ:ICUI) Trading At A 44% Discount?

Jan 31
Is ICU Medical, Inc. (NASDAQ:ICUI) Trading At A 44% Discount?

ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business

Jan 04
ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business

These 4 Measures Indicate That ICU Medical (NASDAQ:ICUI) Is Using Debt Extensively

Oct 28
These 4 Measures Indicate That ICU Medical (NASDAQ:ICUI) Is Using Debt Extensively

Is There An Opportunity With ICU Medical, Inc.'s (NASDAQ:ICUI) 37% Undervaluation?

Oct 07
Is There An Opportunity With ICU Medical, Inc.'s (NASDAQ:ICUI) 37% Undervaluation?

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Jul 19
ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Calculating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Jun 22
Calculating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Here's Why ICU Medical (NASDAQ:ICUI) Can Afford Some Debt

Apr 03
Here's Why ICU Medical (NASDAQ:ICUI) Can Afford Some Debt

Estimating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Feb 27
Estimating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Dec 07
ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Sep 07
ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

ICU Medical Hit Hard As Smiths Medical Needs Significant TLC

Aug 20

ICU Medical Non-GAAP EPS of $1.37 misses by $0.29, revenue of $561M misses by $3.1M

Aug 08

FDA labels ICU Medical unit's April recall of syringe infusion pumps as most serious

Jul 20

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Jun 08
ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

ICU Medical: There Is Still Upside Here As Management Goes Big To Drive Value

Mar 25

A Look At The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Feb 23
A Look At The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Analysts Just Made A Significant Upgrade To Their ICU Medical, Inc. (NASDAQ:ICUI) Forecasts

Jan 28
Analysts Just Made A Significant Upgrade To Their ICU Medical, Inc. (NASDAQ:ICUI) Forecasts

Is Now The Time To Put ICU Medical (NASDAQ:ICUI) On Your Watchlist?

Dec 05
Is Now The Time To Put ICU Medical (NASDAQ:ICUI) On Your Watchlist?

A Look At The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Nov 04
A Look At The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

ICU Medical: Decisive M&A, Again

Sep 10

Is Now The Time To Put ICU Medical (NASDAQ:ICUI) On Your Watchlist?

Sep 05
Is Now The Time To Put ICU Medical (NASDAQ:ICUI) On Your Watchlist?

Some Investors May Be Worried About ICU Medical's (NASDAQ:ICUI) Returns On Capital

Jul 30
Some Investors May Be Worried About ICU Medical's (NASDAQ:ICUI) Returns On Capital

Calculating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Jun 27
Calculating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Here's Why I Think ICU Medical (NASDAQ:ICUI) Is An Interesting Stock

May 28
Here's Why I Think ICU Medical (NASDAQ:ICUI) Is An Interesting Stock

Why We Think ICU Medical, Inc.'s (NASDAQ:ICUI) CEO Compensation Is Not Excessive At All

May 05
Why We Think ICU Medical, Inc.'s (NASDAQ:ICUI) CEO Compensation Is Not Excessive At All

There Are Reasons To Feel Uneasy About ICU Medical's (NASDAQ:ICUI) Returns On Capital

May 01
There Are Reasons To Feel Uneasy About ICU Medical's (NASDAQ:ICUI) Returns On Capital

Earnings and Revenue Growth Forecasts

NasdaqGS:ICUI - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,388913324021
12/31/20252,375252423385
12/31/20242,288-462021675
12/31/20232,259-3073166N/A
9/30/20232,249-28-1373N/A
6/30/20232,294-48-4440N/A
3/31/20232,306-46-110-20N/A
12/31/20222,280-74-161-62N/A
9/30/20222,043-39-7822N/A
6/30/20221,7815-199N/A
3/31/20221,54141124215N/A
12/31/20211,316103186268N/A
9/30/20211,296109175263N/A
6/30/20211,279103168260N/A
3/31/20211,26094146235N/A
12/31/20201,27187122223N/A
9/30/20201,2668198193N/A
6/30/20201,2558373168N/A
3/31/20201,2648760162N/A
12/31/20191,266101-4102N/A
9/30/20191,291733103N/A
6/30/20191,311471104N/A
3/31/20191,3595557160N/A
12/31/20181,4002959160N/A
9/30/20181,4308690195N/A
6/30/20181,44686140242N/A
3/31/20181,41718119210N/A
12/31/20171,2936975154N/A
9/30/20171,01828N/A91N/A
6/30/201777247N/A19N/A
3/31/2017537101N/A-4N/A
12/31/201637963N/A90N/A
9/30/201637259N/A84N/A
6/30/201636156N/A77N/A
3/31/201634853N/A68N/A
12/31/201534045N/A64N/A
9/30/201532947N/A61N/A
6/30/201532137N/A61N/A
3/31/201531629N/A61N/A
12/31/201430726N/A66N/A
9/30/201430632N/A72N/A
6/30/201431137N/A69N/A
3/31/201431138N/A68N/A
12/31/201331240N/A66N/A
9/30/201331839N/A68N/A
6/30/201331741N/A61N/A
3/31/201331642N/A59N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ICUI is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).

Earnings vs Market: ICUI is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: ICUI is expected to become profitable in the next 3 years.

Revenue vs Market: ICUI's revenue (2.4% per year) is forecast to grow slower than the US market (8.2% per year).

High Growth Revenue: ICUI's revenue (2.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ICUI's Return on Equity is forecast to be low in 3 years time (4.2%).


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.